Core Viewpoint - Beihai Kangcheng-B (01228) experienced a decline of over 10%, with a current drop of 10.95%, trading at HKD 1.87, and a transaction volume of HKD 42.334 million [1] Group 1: Subscription Agreement - Beihai Kangcheng-B announced a subscription agreement with Baiyang Health Industry International Trade Co., Ltd., allowing the company to conditionally issue and the subscriber to conditionally subscribe for 74.9715 million subscription shares at a price of HKD 1.34 per share [1] - The subscription price of HKD 1.34 represents a discount of approximately 19.76% compared to the closing price of HKD 1.67 on the last trading day, August 11, 2025 [1] Group 2: Fund Utilization - The total amount raised from the subscription will be HKD 100 million, with an estimated net amount of approximately HKD 98.6618 million after deducting related expenses [1] - The company plans to use the net proceeds from the subscription for the research and development of commercialized products, marketing and promotional activities, repayment of loan financing and borrowings, and daily operations of the group [1]
北海康成-B回落逾10% 近日拟折让约19.76%向百洋医药发行7497.15万股认购股份